Pharmaceutical preparation manufacturing federal obligations in North Carolina (NAICS 325412)

What the 325412–North Carolina join is

NAICS 325412 and geography NC meet here. $731,485,275.57 is the USAspending.gov obligation sum on awards that carry both tags. It is not the nationwide pharma preparation manufacturing book, not North Carolina’s entire federal inflow, and not an outlay. Wholesale, PBM, and retail pharmacy codes sit elsewhere. Pennsylvania and New York have separate 325412 cells.

238 awards is a moderate factory list beside $731,485,275.57. A mid-size row count can still hold a large commitment if a few preparation vehicles dominate. The packet does not name FDA, vaccines, or a Research Triangle plant inside the extract. Treating 238 as a count of North Carolina pharmacies would misread award records. Those labels are ordinary speech, not extra packet dollars.

Open North Carolina federal spending for every industry tagged to the state, NAICS 325412 for 325412 without a North Carolina filter, North Carolina industries for other North Carolina NAICS pairs, and All spending ties for joins outside this pharma preparation manufacturing cell. Do not add those parents into $731,485,275.57.

A finished-dose book, not a drugstore tally

Dividing $731,485,275.57 by 238 awards yields about $3.07 million per award. That mean is a ratio of two packet facts, not a typical Research Triangle fill-finish line and not a typical Piedmont plant order. Unique recipients are unpublished. 238 is not a count of SKUs, lots, or pharmacies.

North Carolina geography invites a Triangle-versus-Piedmont factory story. This extract does not split those regions. All share NC inside $731,485,275.57. New York’s thicker 325412 book and Pennsylvania’s 325412 cell are separate joins.

Nationwide 325412 without a North Carolina overlay is a different total

The national industry hub aggregates 325412 across every state. North Carolina’s statewide hub aggregates every NAICS with an NC tag. Only awards that carry both 325412 and North Carolina place of performance belong here, which is why this page cites 238 awards and $731,485,275.57.

Place of performance can follow a payee address, in-state work, or a reporting convention. 325412 awards coded to Virginia, South Carolina, or New Jersey do not enter this sum even if a vendor’s mailroom sits in Durham. The join cannot re-allocate dollars along a Mid-Atlantic pharma chain.

Obligations, not outlays, on the North Carolina 325412 cell

An obligation is a legal commitment. An outlay is a payment. $731,485,275.57 is the former. This packet has no outlay total, no fiscal-year split, and no de-obligation history. Citing the figure as doses already shipped from North Carolina over-reads the field. 238 remains an award-record count, not a payment count.

What the North Carolina–325412 pair does not prove

A large pharma preparation manufacturing total in North Carolina does not mean the code caused North Carolina’s industry mix, and it does not connect these obligations to campaign contributions. Correlation is not causation. Approvals, shortages, and list prices are not USAspending columns here.

Keep $731,485,275.57 labeled as NAICS 325412 obligations with North Carolina place of performance. North Carolina federal spending still includes other industries that must not be folded into this pharma preparation manufacturing cell. NAICS 325412 is 325412 without the North Carolina filter. North Carolina industries lists sibling North Carolina codes.

How to cite pharma preparation in North Carolina

A clean footnote names NAICS 325412 (pharma preparation manufacturing), North Carolina place of performance, $731,485,275.57 in obligations, and 238 awards on USAspending.gov. Keep the obligation word. Mean dollars per action remain about $3.07 million. Do not merge PBM or retail-pharmacy NAICS into this factory bucket. All spending ties indexes other pairs.

A later ingest can restate $731,485,275.57 without changing the join of 325412 and NC. North Carolina federal spending still mixes every North Carolina industry; do not quote that parent as 325412. NAICS 325412 is the national pharma preparation manufacturing code without the North Carolina tag. North Carolina industries keeps sibling North Carolina codes unmerged. 238 is a record count, including modifications, not a unique-vendor census. Keep the obligation label on $731,485,275.57. Correlation is not causation. Triangle folklore is not a metro split in this packet.

Questions

How much has NAICS 325412 obligated in North Carolina?

USAspending.gov records $731,485,275.57 in obligations for NAICS 325412 with North Carolina place of performance, covering 238 awards. That is an obligation aggregate for the pharma preparation manufacturing–North Carolina pair, not an outlay figure and not the nationwide 325412 total. Original filings remain on USAspending.gov.

Is this North Carolina pharmacy-benefit spending?

No. NAICS 325412 is pharmaceutical preparation manufacturing, not PBM or retail pharmacy. $731,485,275.57 covers 238 awards with North Carolina place of performance under that factory code. Quote 325412 and North Carolina together. Original filings remain on USAspending.gov.

Does this include New York or Pennsylvania 325412 awards?

No. Those states have separate 325412 joins. $731,485,275.57 and 238 describe North Carolina place of performance only. Do not add sibling-state preparation books into this total. Keep the North Carolina geography tag on the citation. Original filings remain on USAspending.gov.

Where are the live North Carolina and 325412 tables?

North Carolina federal spending shows all industries in the state. NAICS 325412 shows NAICS 325412 without a state filter. North Carolina industries lists other North Carolina industry pairs. All spending ties lists joins outside this cell. Prefer those hubs after later USAspending ingests.